GC Cell Corporation

KOSDAQ:A144510 주식 보고서

시가총액: ₩473.4b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

GC Cell 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

James Park

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기no data
CEO 소유권0.1%
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간데이터 없음

최근 관리 업데이트

Recent updates

Is GC Cell (KOSDAQ:144510) A Risky Investment?

Sep 08
Is GC Cell (KOSDAQ:144510) A Risky Investment?

We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative

Mar 19
We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative

We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt

Feb 22
We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt

Can Green Cross Lab Cell Corporation (KOSDAQ:144510) Improve Its Returns?

Jan 18
Can Green Cross Lab Cell Corporation (KOSDAQ:144510) Improve Its Returns?

Can You Imagine How Jubilant Green Cross Lab Cell's (KOSDAQ:144510) Shareholders Feel About Its 139% Share Price Gain?

Dec 14
Can You Imagine How Jubilant Green Cross Lab Cell's (KOSDAQ:144510) Shareholders Feel About Its 139% Share Price Gain?

CEO

James Park (58 yo)

no data

테뉴어

Mr. James Park is Chairman of the Board of BioCentriq, Inc and was its Interim CEO. He had been a Director of Artiva Biotherapeutics, Inc. since January 2023 until July 2024. He served as Executive VP at S...